Skip to the page content
Your donations
Passes our checks

Idsa Education and Research Foundation

EIN 31-1765388 · Arlington, VA

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthWeak24 out of 100GovernanceStrong100 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

THE IDSA FOUNDATION, THE 501(C)(3) CHARITABLE ARM OF THE INFECTIOUS DISEASES SOCIETY OF AMERICA, COMPLEMENTS IDSA'S MISSION BY SECURING PHILANTHROPIC AND INDUSTRY SUPPORT TO ADVANCE ITS STRATEGIC PRIORITIES. THE FOUNDATION STRENGTHENS THE INFECTIOUS DISEASES WORKFORCE, PROMOTES INCLUSION AND EQUITY, AND EXPANDS IDSA'S CAPACITY TO LEAD IN RESEARCH, PREPAREDNESS, AND PUBLIC HEALTH RESPONSEENSURING LASTING IMPACT IN THE FIGHT AGAINST INFECTIOUS DISEASES.

Income
$2.0 million
Spending
$2.1 million
Spent on programs
65%
Reserves
-2.5 months of spending
Largest source of income
donations and private grants, 99%
Employees
0
Volunteers
105
Highest pay
$813,135, chief executive officer

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Weak: 24 out of 100. Higher than 3% of charities in its peer group (health care, $1m to $10m).

  • Reserves

    0 of 35

    Spendable reserves are negative: it owes or has committed more than it holds.

  • Debt

    5 of 20

    It owes 69% of what it owns.

  • Living within its means

    4 of 15

    Spending exceeded income by 6% of income.

  • Income trend

    0 of 15

    Income fell 30% on the year before.

  • Spending floor

    15 of 15

    65% of spending went to programs and raising each dollar of donations cost 9 cents.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Strong: 100 out of 100. Higher than 67% of charities in its peer group (health care, $1m to $10m).

  • Independent board

    25 of 25

    6 of 6 voting board members are independent.

  • Conflict of interest policy

    15 of 15

    Has a written conflict of interest policy.

  • Whistleblower policy

    8 of 8

    Has a written whistleblower policy.

  • Record keeping policy

    7 of 7

    Has a written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    5 of 5

    Sets its chief executive's pay through independent review and comparison.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (9)
  1. $97,677 spent. THE MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE PROGRAM (ALZ/ID) WAS LAUNCHED TO SUPPORT INNOVATIVERESEARCH THAT MAY LINK INFECTIOUS DISEASES AND ALZHEIMER'S DISEASE. THIS RESEARCH INCLUDES BASIC,CLINICAL AND/OR NON-TRADITIONAL RESEARCH APPROACHES ACROSS A WIDE RANGE OF DISCIPLINES INCLUDING NEUROLOGY, MICROBIOLOGY, PATHOLOGY, VIROLOGY, AND BACTERIOLOGY. IN 2022, IDSA FOUNDATION RECEIVED GRANTS TOTALING $3.3 MILLION TO FUND RESEARCH AWARDS FOR THIS PROGRAM. IN 2023, AWARDS OF APPROXIMATELY $2.5 MILLION WERE GRANTED TO RESEARCHERS, IN ADDITION TO OTHER INCURRED EXPENSES RELATED TO THE PROGRAM. DUE TO THE REQUIREMENTS OF GENERALLY ACCEPTED ACCOUNTING PRINCIPLES (GAAP), THE TIMING OF THE REVENUE AND EXPENSE RECOGNITION CREATED A LARGE SURPLUS IN 2022 AND A LARGE DEFICIT IN 2023. IN 2023, THE PROGRAM LAUNCHED THE FIRST MICROBIAL PATHOGENESIS IN ALZHEIMER'S DISEASE SYMPOSIUM, PROVIDED ONGOING ASSISTANCE AND MONITORING FOR EXISTING GRANTEES. NO ADDITIONAL GRANTS WERE ISSUED IN 2024, ALTHOUGH ADDITIONAL FUNDS ARE AVAILABLE FOR GRANTS IN 2025.
  2. $215,728 spent. G.E.R.M.GERM - THE GERM PROGRAM WAS DEVELOPED TO PROVIDE MEDICAL STUDENTS WITH MENTORED CLINICAL LEARNINGAND/OR RESEARCH EXPERIENCE IN INFECTIOUS DISEASES-RELATED TOPICS, INCLUDING HIV. IN 2024, 75 PEOPLE APPLIED TO THE GERM PROGRAM AND 40 $4,000 GRANTS WERE AWARDED TOTALING $160,000. THE GOAL OF THE G.E.R.M. PROGRAM IS TO INCREASE INTEREST AMONG UNDERGRADUATE MEDICAL STUDENTS, PARTICULARLY AMONG POPULATIONS UNDERREPRESENTED IN MEDICINE, IN PURSUING ID FELLOWSHIP POST-GRADUATE TRAINING OR A CAREER IN HIV MEDICINE BY PROVIDING MENTOR-BASED RESEARCH OR CLINICAL TRAINING; IMPROVING ANALYTIC, RESEARCH AND CLINICAL SKILLS OF MEDICAL STUDENTS; INCREASING THE NUMBER AND DIVERSITY OF THE ID/HIV RESEARCH AND CLINICAL WORKFORCE. ELIGIBLE APPLICANTS INCLUDED FIRST-, SECOND-, AND THIRD YEAR MEDICAL STUDENTS AND THOSE IN COMBINED DEGREE PROGRAMS (MD/MPH, MD/PHD) FROM ACCREDITED ALLOPATHIC OR OSTEOPATHIC MEDICAL SCHOOLS IN THE U.S. APPLICATIONS WERE REVIEWED AND SCORED BY AN EXPERT PANEL OF INFECTIOUS DISEASE SPECIALISTS.
  3. $125,962 spent. HIV CLINICAL FELLOWSHIP PROGRAMHIV CLINICAL FELLOWSHIP PROGRAM - THE GOAL OF THE HIV CLINICAL FELLOWSHIP PROGRAM IS TO PROVIDE NON-ID TRAINED PHYSICIANS WITH THE MOST UPDATED BEST PRACTICES FOR TREATING PATIENTS LIVING WITH HIV. CLINICAL TRAINING INCLUDES MANAGEMENT OF ANTIRETROVIRAL THERAPY, TREATING COMMON CO-INFECTIOUS AND COMORBIDITIES AND MULTIDISCIPLINARY TEAM-BASED CARE. FELLOWS ARE SUPPORTED FOR UP TO TWO YEARS DURING WHICH TIME THEY MANAGE THE CARE OF A MINIMUM OF 30 PATIENTS, UNDER THE SUPERVISION OF AN HIV MEDICAL ASSOCIATION MENTOR. IN 2024, ONE FELLOW WAS FUNDED WITH A $120,436 AWARD.
  4. $76,142 spent. IDEA INCUBATORTHE IDEA INCUBATOR PROGRAM IS A PITCH-STYLE COMPETITION FOR INNOVATIONS IN THE FIELD OF INFECTIOUS DISEASES. THE PROGRAM ENCOURAGES INNOVATORS WITH ORIGINAL INVENTIONS, PRODUCTS AND IDEAS THAT CAN IMPROVE INFECTIOUS DISEASE CARE TO APPLY. INNOVATIONS ARE SHARED WITH THE ID COMMUNITY AND JUDGED BY INDIVIDUALS FROM BUSINESSES, MEDICAL AND TECHNOLOGY FIELDS. THREE WINNING INDIVIDUALS/TEAMS ARE SELECTED FROM THOSE THAT APPLY. FINALISTS PRESENT THEIR INNOVATIONS AT THE ANNUAL IDWEEK CONFERENCE AND WERE AWARDED A TOTAL OF $35,000 IN CASH PRIZES. FOR 2024, THE WINNER WAS AWARDED $15,000, AND SECOND AND THIRD PRIZES WERE AWARDED $10,000 EACH.
  5. $174,819 spent. MENTORSHIPTHE IDWEEK MENTORSHIP PROGRAM OFFERS OPPORTUNITIES FOR MENTORSHIP AND NETWORKING THROUGH ONE-ON-ONE INTERACTIONS BETWEEN LEADERS IN THE FIELD AND FELLOWS, RESIDENTS AND MEDICAL STUDENTS DURING IDWEEK.
  6. $14,651 spent. ID STEP
  7. $2,250 spent. WATANAKUNAKORN TRAVEL
  8. $1,221 spent. MOELLERING TRAVEL
  9. $644,754 spent. GENERAL PROGRAM SERVICES

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since December 2002.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.